Clinical Trials Logo

Clinical Trial Summary

Osteoarthritis (OA) is a common and incurable disease for the elderly in Taiwan, so it is an important mission to develop a new treatment for OA. Recently, cellular therapy is a new and popular medical treatment around the world, one of them is "Mesenchymal Stromal Cells (MSCs)". MSCs are found in many tissues of human body and play an important role for repairing, regeneration, anti-inflammatory and chondrogenesis. So, MSC product, RegStem, for osteoarthritis treatment becomes a developing target for new generation drugs.

This study is to isolate and expand MSCs(RegStem) from infrapatellar fat pad of subject. When the number of MSCs expands to 1×10^8, cell will be cryopreserved in the liquid nitrogen tank until all release tests passed. On the distribution day, cell will be thawed and injected into joint cavity of patient (5×10^7). Subjects will be monitored after MSC product infusion of seven days, one month, six months and one year. The monitoring items include the changes of knee (by appearance, X-ray and MRI of knee) and pain improvement (by questionnaire).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03007576
Study type Interventional
Source EMO Biomedicine Corporation
Status Completed
Phase Phase 1
Start date August 1, 2017
Completion date August 31, 2019

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02784041 - Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty N/A
Completed NCT02966613 - Fully Disposable Patient-Specific Instrumentation N/A
Recruiting NCT03074994 - The Comparative Efficacy of Peri-articular and Intraarticular Tranexamic Acid in Total Knee Arthroplasty Phase 2
Completed NCT00137410 - Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee Phase 3
Recruiting NCT03360500 - Cryotherapy Associated With Exercise in Pain Control and Physical Function in Individuals With Knee Osteoarthritis N/A
Completed NCT02967874 - Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment Phase 1/Phase 2
Completed NCT01899417 - Costs and Benefits of ConforMIS iTotal® Knee Replacement System Versus Standard Total Knee N/A
Completed NCT02967744 - NSAID Treatment of Patients With Osteoarthritis N/A
Completed NCT01042093 - Efficacy of Multimodal Perioperative Analgesia With Periarticular Drug Injection in Total Knee Arthroplasty(TKA) N/A
Completed NCT03033238 - Multicenter Bone and Joint Health Study
Completed NCT03011112 - Can 3D Kinematic Parameters Assess the Symptomatic and Functional Severity of KOA? N/A
Completed NCT02975154 - Microcurrent Therapy in the Treatment of Osteoarthritis of the Knee N/A
Completed NCT03684850 - Knee Brace and Biomechanical Footwear in the Treatment of Knee Osteoarthritis. N/A